Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07570784
Stability of Hand Grip Strength Across a Competitive Season in Elite Male and Female Ice Hockey PlayersDalarna County Council, SwedenNot Yet Recruiting
NCT07570784Not Yet Recruiting
—
Stability of Hand Grip Strength Across a Competitive Season in Elite Male and Fe...Dalarna County Council, S...
NCT07571070
High-Intensity Intermittent Training and Sport-Specific Performance in Youth Amateur BoxersFederal University of VicosaCompletedNot Applicable
NCT07571070Completed
Not Applicable
High-Intensity Intermittent Training and Sport-Specific Performance in Youth Ama...Federal University of Vic...
NCT07570914
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesTianjin Medical University Cancer Institute and HospitalNot Yet RecruitingPhase 2
NCT07570914Not Yet Recruiting
Phase 2
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitab...Tianjin Medical Universit...
NCT07571681
Colchicine for Autoimmune and Subacute ThyroiditisMansoura UniversityNot Yet RecruitingPhase 2
NCT07571681Not Yet Recruiting
Phase 2
Colchicine for Autoimmune and Subacute ThyroiditisMansoura University
NCT07569042
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed GlioblastomaNovelwise Pharmaceutical CorporationRecruitingPhase 1
NCT07569042Recruiting
Phase 1
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Ne...Novelwise Pharmaceutical...
NCT07571928
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive AzoospermiaMartin Blomberg JensenNot Yet RecruitingPhase 1
NCT07571928Not Yet Recruiting
Phase 1
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoo...Martin Blomberg Jensen
NCT07570355
Pterygopalatine Ganglion Stimulation for the Treatment of Geographic AtrophyShanghai Institute of Acupuncture, Moxibustion and MeridianNot Yet RecruitingNot Applicable
NCT07570355Not Yet Recruiting
Not Applicable
Pterygopalatine Ganglion Stimulation for the Treatment of Geographic AtrophyShanghai Institute of Acu...
NCT07569939
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral TonsillitisUniversity Hospital, Clermont-FerrandNot Yet RecruitingNot Applicable
NCT07569939Not Yet Recruiting
Not Applicable
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/o...University Hospital, Cler...
NCT07570069
Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy ParticipantsVertex Pharmaceuticals IncorporatedNot Yet RecruitingPhase 1
NCT07570069Not Yet Recruiting
Phase 1
Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participa...Vertex Pharmaceuticals In...
NCT07568587
Myocardial Function Recovery Prediction Post Primary PCI Using the Estimate of Myocardial Salvage in Gated SPECT Early After Acute Myocardial InfarctionFayoum UniversityCompleted
NCT07568587Completed
—
Myocardial Function Recovery Prediction Post Primary PCI Using the Estimate of M...Fayoum University
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07568782
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.Lille UniversityNot Yet Recruiting
NCT07568782Not Yet Recruiting
—
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Im...Lille University
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570186
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male ParticipantsOnconic Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07570186Not Yet Recruiting
Phase 1
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy...Onconic Therapeutics Inc.
NCT07569861
Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia SyndromeUniversity Hospital, Basel, SwitzerlandNot Yet RecruitingNot Applicable
NCT07569861Not Yet Recruiting
Not Applicable
Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of P...University Hospital, Base...
NCT07571369
Stress Modulation and Dynamic BalanceKafrelsheikh UniversityNot Yet RecruitingNot Applicable
NCT07571369Not Yet Recruiting
Not Applicable
Stress Modulation and Dynamic BalanceKafrelsheikh University
NCT07571863
Radiographic And Histomorphometric Assessment Following Alveolar Ridge Preservation Using Chitosan Gel Versus Normal Socket Healing In Posterior Maxillary and Mandibular RegionCairo UniversityCompletedNot Applicable
NCT07571863Completed
Not Applicable
Radiographic And Histomorphometric Assessment Following Alveolar Ridge Preservat...Cairo University
NCT07570004
THE EFFECT OF PREOPERATIVE ABDOMINAL MASSAGE ON THE POSTOPERATIVE CONSTIPATIONBurcu OzkanCompletedNot Applicable
NCT07570004Completed
Not Applicable
THE EFFECT OF PREOPERATIVE ABDOMINAL MASSAGE ON THE POSTOPERATIVE CONSTIPATIONBurcu Ozkan
NCT07570979
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate CancerNovartis PharmaceuticalsRecruitingPhase 1
NCT07570979Recruiting
Phase 1
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent o...Novartis Pharmaceuticals
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Completed4 (20%)
not_applicable8 (40%)
Phase 15 (25%)
Not Specified4 (20%)
Phase 23 (15%)